文献

J-GLOBAL ID：202002279981023539   整理番号：20A2544510

未治療の原発性免疫性血小板減少症の子供の第一選択治療である伝統的プレドニソンの代替としての高用量デキサメタゾン:前向き無作為化単一施設研究

High-dose dexamethasone as a replacement for traditional prednisone as the first-line treatment in children with previously untreated primary immune thrombocytopenia: a prospective, randomized single-center study

著者 (18件)： Ma Jie (Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China) ,  Ma Jie (Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China) ,  Ma Jie (Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China) ,  Fu Lingling (Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China) ,  Fu Lingling (Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China) ,  Fu Lingling (Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China) ,  Chen Zhengping (Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China) ,  Chen Zhengping (Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China) ,  Chen Zhengping (Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China) ,  Gu Hao (Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China) ,  Gu Hao (Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China) ,  Gu Hao (Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China) ,  Ma Jingyao (Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China) ,  Ma Jingyao (Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China) ,  Ma Jingyao (Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China) ,  Wu Runhui (Department of Hematology and Oncology, Beijing Children’s Hospital, Capital Medical University, Beijing, People’s Republic of China) ,  Wu Runhui (Beijing Key Laboratory of Pediatric Hematology Oncology, National Center for Children’s Health, Beijing, China) ,  Wu Runhui (Key Laboratory of Major Diseases in Children, Ministry of Education, National Key Discipline of Pediatrics (Capital Medical University), Beijing, China)
資料名： International Journal of Hematology  (International Journal of Hematology)
巻： 112  号： 6  ページ： 773-779  発行年： 2020年12月 
JST資料番号： F0888A  ISSN： 0925-5710  CODEN： IJHEEY  資料種別： 逐次刊行物 (A)
記事区分： 原著論文  発行国： ドイツ (DEU)  言語： 英語 (EN)

抄録/ポイント： 要約:免疫血小板減少症(ITP)は,子供に見られる最も一般的...

シソーラス用語： ヒト ,...
準シソーラス用語： *免疫性血小板減少症 ,...

ログイン（無料）して見る     続きはJDreamIII（有料）にて  {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=20A2544510&from=J-GLOBAL&jstjournalNo=F0888A") }}

著者キーワード (4件)： 高用量デキサメタゾン ,  小児 ,  免疫性血小板減少症 ,  第一線治療

分類 (2件)： 副腎ホルモン  (EB08040D) ,  血液疾患の薬物療法  (GK05020P)

物質索引 (2件)： デキサメタゾン ,  プレドニゾン

タイトルに関連する用語 (10件)： 治療 ,  原発 ,  免疫性血小板減少症 ,  子供 ,  プレドニソン ,  代替 ,  高用量 ,  デキサメタゾン ,  施設 ,  研究